Commercialized a highly effective skin cancer scanning device

Used for over 12 years and supported by more than 15 published clinical studies

Sponsored
Message: Another Slap.

This is not what shareholders are wanting to see another slap in the stock price. There is something wrong why this stock is not in the .30 to .40 cent range or even higher. Up to .14/.15 cent then back down, contant frustration to all that hold this stock. To many years of this happening and always wait till this quarter or that quarter come on lets get something going. I hate being like this but lets see some improvement in the share price. This is getting ridiculous.

Share
New Message
Please login to post a reply